| 2021-09-20 | Stubblefield Michael | President and CEO | Sell | 141,300 | $42.37 | $5,986,881.00 | -10.1% | → |
| 2021-09-01 | GUPTA RAJIV | - | Sell | 100,000 | $39.45 | $3,945,000.00 | -7.8% | → |
| 2021-08-26 | Eck Steven W | SVP & Chief Accounting Officer | Sell | 17,383 | $40.08 | $696,710.64 | -55.1% | → |
| 2021-08-20 | GUPTA RAJIV | - | Sell | 100,000 | $38.81 | $3,881,000.00 | -7.2% | → |
| 2021-07-30 | Brophy Gerard | EVP, Biopharma Production | Sale+OE | 81,125 | $37.24 | $3,021,095.00 | -35.2% | → |
| 2021-07-20 | Bramwell James | EVP, Strategic Partners | Sell | 6,112 | $37.00 | $226,144.00 | -7.1% | → |
| 2021-07-12 | Natauri Jo | Director | Buy | 300 | $36.33 | $10,900.20 | - | → |
| 2021-07-09 | Bramwell James | EVP, Strategic Partners | Sell | 18,331 | $35.61 | $652,828.04 | -9.0% | → |
| 2021-06-28 | Couturier Christophe | EVP, AMEA | Sell | 28,096 | $35.73 | $1,003,870.08 | -20.3% | → |
| 2021-06-25 | GUPTA RAJIV | - | Sell | 68,605 | $35.32 | $2,423,128.60 | -4.7% | → |
| 2021-06-10 | Stubblefield Michael | President and CEO | Sale+OE | 487,700 | $32.13 | $15,667,506.58 | -8.0% | → |
| 2021-05-27 | Ohri Devashish | EVP, IMEA | Sale+OE | 100,000 | $31.99 | $3,199,000.00 | -41.8% | → |
| 2021-05-27 | GUPTA RAJIV | - | Sell | 228,109 | $31.91 | $7,278,301.46 | -26.4% | → |
| 2021-05-26 | Ohri Devashish | EVP, IMEA | Sale+OE | 15,000 | $31.87 | $478,050.00 | -9.7% | → |
| 2021-05-24 | GUPTA RAJIV | - | Sell | 337,571 | $31.66 | $10,687,716.47 | -22.4% | → |
| 2021-05-24 | Ohri Devashish | EVP, IMEA | Sale+OE | 9,124 | $31.75 | $289,687.00 | -6.2% | → |
| 2021-05-21 | Wondrasch Michael | EVP & CIO | Sell | 18,488 | $31.41 | $580,708.08 | -14.0% | → |
| 2021-05-20 | Miller Justin | EVP & General Counsel | Sell | 18,488 | $31.12 | $575,346.56 | -17.6% | → |
| 2021-05-20 | Couturier Christophe | EVP, AMEA | Sell | 25,010 | $31.13 | $778,561.30 | -15.3% | → |
| 2021-05-20 | Brophy Gerard | EVP, Biopharma Production | Sell | 19,603 | $31.10 | $609,653.30 | -11.6% | → |
| 2021-05-11 | Natauri Jo | Director | Sell | 2,626,771 | $30.68 | $80,589,334.28 | -9.6% | → |
| 2021-04-30 | Ohri Devashish | EVP, IMEA | Sale+OE | 53,649 | $32.58 | $1,747,884.42 | -25.6% | → |
| 2021-04-12 | Ohri Devashish | EVP, IMEA | Sale+OE | 100,160 | $32.37 | $3,242,179.20 | -39.1% | → |
| 2021-04-12 | Vanderhaegen Frederic | EVP, Europe | Sell | 27,075 | $31.80 | $860,997.25 | -5.7% | → |
| 2021-04-12 | Bramwell James | EVP, Strategic Partners | Sell | 2,505 | $32.00 | $80,160.00 | -2.1% | → |
| 2021-04-12 | Miller Justin | EVP & General Counsel | Sale+OE | 102,895 | $33.17 | $3,412,916.25 | -30.2% | → |
| 2021-03-09 | Vanderhaegen Frederic | EVP, Europe | Sell | 10,000 | $28.21 | $282,100.00 | -3.9% | → |
| 2021-03-02 | Wondrasch Michael | EVP & CIO | Sell | 3,036 | $28.71 | $87,163.56 | -2.0% | → |
| 2021-02-24 | Brophy Gerard | EVP, Biopharma Production | Sell | 3,059 | $27.93 | $85,437.87 | -1.7% | → |
| 2021-02-22 | Brophy Gerard | EVP, Biopharma Production | Sale+OE | 19,769 | $28.62 | $565,788.78 | -10.1% | → |
| 2021-02-05 | Wondrasch Michael | EVP & CIO | Sale+OE | 49,468 | $29.77 | $1,472,662.36 | -14.9% | → |
| 2021-01-11 | Bramwell James | EVP, Strategic Partners | Sell | 2,505 | $30.00 | $75,150.00 | -2.1% | → |
| 2021-01-11 | Brophy Gerard | EVP, Biopharma Production | Sale+OE | 378,580 | $30.06 | $11,381,196.48 | -51.5% | → |
| 2021-01-06 | Brophy Gerard | EVP, Biopharma Production | Sell | 11,509 | $27.24 | $313,505.16 | -6.1% | → |
| 2021-01-04 | Brophy Gerard | EVP, Biopharma Production | Sale+OE | 59,418 | $27.84 | $1,654,197.12 | -23.8% | → |
| 2020-12-21 | Bramwell James | EVP, Strategic Partners | Sell | 10,020 | $27.14 | $271,942.80 | -7.8% | → |
| 2020-12-11 | Shaw Christi | - | Sell | 14,286 | $26.68 | $381,150.48 | -55.8% | → |
| 2020-12-07 | Stubblefield Michael | President and CEO | Sale+OE | 510,640 | $27.15 | $13,864,558.44 | -12.5% | → |
| 2020-11-10 | New Mountain Investments III, LLC | 10% Owner | Sell | 36,016,093 | $24.81 | $893,490,836.75 | -56.3% | → |